In exploratory analyses of patients with ED-SCLC and high CXCR4-expressing tumors at baseline (H-score ≥ 210), the hazard ratio (HR) for PFS between the treatment arms was 0.787 (95% confidence interval [CI]: 0.211, 2.933) [24]. Here, CXCR4 is linked to small cell lung carcinoma.